Omentin-1 Is Decreased in Maternal Plasma, Placenta and Adipose Tissue of Women with Pre-Existing Obesity

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Barker, Gillian ^a   Lim, Ratana ^a   Georgiou, Harry M ^a   Lappas, Martha ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; OMENTIN 1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MATERNAL OBESITY; MATERNAL PLASMA; OMENTIN 1 GENE; PLACENTA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PUERPERIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UMBILICAL CORD BLOOD;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; CYTOKINES; DIABETES, GESTATIONAL; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LECTINS; OBESITY; PLACENTA; PLASMA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; TISSUE DISTRIBUTION;

EID: 84865492816     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042943     Document Type: Article

References (39)

1. Salihu HM, Mbah AK, Alio AP, Kornosky JL, Bruder K, et al. (2009) Success of programming fetal growth phenotypes among obese women. Obstet Gynecol 114: 333-339.
2. Baptiste-Roberts K, Barone BB, Gary TL, Golden SH, Wilson LM, et al. (2009) Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 122: 207-214 e204.
3. Agarwal MM, Dhatt GS, Punnose J, Koster G, (2005) Gestational diabetes: dilemma caused by multiple international diagnostic criteria. Diabet Med 22: 1731-1736.
4. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, et al. (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352: 2477-2486.
5. Chu SY, Bachman DJ, Callaghan WM, Whitlock EP, Dietz PM, et al. (2008) Association between obesity during pregnancy and increased use of health care. New England Journal of Medicine 358: 1444-1453.
6. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J, (2003) Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 133: 1674S-1683S.
7. Pathmaperuma AN, Mana P, Cheung SN, Kugathas K, Josiah A, et al. (2010) Fatty acids alter glycerolipid metabolism and induce lipid droplet formation, syncytialisation and cytokine production in human trophoblasts with minimal glucose effect or interaction. Placenta 31: 230-239.
8. Yang RZ, Xu AH, Pray J, Hong H, Jadhao S, et al. (2003) Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes 52: A1-A1.
9. Batista C, Yang RZ, Lee MJ, Glynn NM, Yu DZ, et al. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56: 1655-1661.
10. Cai R-C, Wei L, Di J-Z, Yu H-Y, Bao Y-Q, et al. (2009) Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua yi xue za zhi 89: 381-384.
11. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, et al. (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Medical Genetics 12: 60.
12. Fu M, Gong DW, Damcott C, Sabra M, Yang RZ, et al. (2004) Systematic analysis of omentin 1 and omentin 2 on 1q23 as candidate genes for type 2 diabetes in the old order Amish. Diabetes 53: A59-A59.
13. Yan P, Liu D, Long M, Ren Y, Pang J, et al. (2011) Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 119: 257-263.
14. Pan HY, Guo L, Li Q, (2010) Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Research and Clinical Practice 88: 29-33.
15. Liu R, Wang XL, Bu PL, (2011) Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Research and Clinical Practice 93: 21-25.
16. Tan BK, Adya R, Farhatullah S, Lewandowski KC, O'Hare P, et al. (2008) Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome. Diabetes 57: 801-808.
17. Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, et al. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. American Journal of Physiology- Endocrinology And Metabolism 290: E1253-E1261.
18. Moreno-Navarrete JM, Catalan V, Ortega F, Gomez-Ambrosi J, Ricart W, et al. (2010) Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 7: 27.
19. Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, et al. (2008) Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 45: 157-165.
20. Barker G, Lim R, Rice GE, Lappas M, (2012) Increased chemerin concentrations in fetuses of obese mothers and correlation with maternal insulin sensitivity. The Journal of Maternal-Fetal & Neonatal Medicine.
21. Lappas M, Permezel M, Georgiou HM, Rice GE, (2002) Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67: 668-673.
22. Lappas M, Permezel M, Georgiou HM, Rice GE, (2004) Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro. J Clin Endocrinol Metab 89: 2365-2372.
23. Lappas M, Permezel M, Rice GE, (2003) N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88: 1723-1729.
24. Lappas M, Mitton A, Lim R, Barker G, Riley C, et al. (2011) SIRT1 is a novel regulator of key pathways of human labor. Biol Reprod 84: 167-178.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
26. Krzysztof L, Iwona N, Andrzej L, Malgorzata B, Tan B, et al. (2010) Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekologia Polska 81: 907-912.
27. Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, et al. (2011) Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity 19: 1552-1559.
28. Briana DD, Boutsikou M, Baka S, Gourgiotis D, Marmarinos A, et al. (2011) Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism-Clinical and Experimental 60: 486-490.
29. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, et al. (2007) Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30Suppl 2: S112-119.
30. Bai L, Wang Y, Fan J, Chen Y, Ji W, et al. (2007) Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab 5: 47-57.
31. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M, (2009) Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160: 567-578.
32. Colomiere M, Permezel M, Lappas M, (2010) Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue. J Mol Endocrinol 44: 213-223.
33. Zhong X, Zhang HY, Tan H, Zhou Y, Liu FL, et al. (2011) Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacologica Sinica 32: 873-878.
34. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, et al. (2002) Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. Journal of Clinical Endocrinology & Metabolism 87: 4231-4237.
35. Denison FC, Roberts KA, Barr SM, Norman JE, (2010) Obesity, pregnancy, inflammation, and vascular function. Reproduction 140: 373-385.
36. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, et al. (2011) Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochemical and Biophysical Research Communications 408: 339-343.
37. Reynolds LP, Redmer DA, (2001) Angiogenesis in the placenta. Biology of Reproduction 64: 1033-1040.
38. Hehir MP, Moynihan AT, Glavey SV, Morrison JJ, (2009) Umbilical artery tone in maternal obesity. Reproductive Biology and Endocrinology 7.
39. Lehingue Y, Remontet L, Munoz F, Mamelle N, (1998) Birth ponderal index and body mass index reference curves in a large population. American Journal of Human Biology 10: 327-340.